Calendar

pharmadog

Week of Feb 23, 2026

Feb 27, 2026approval183d agoPREZCOBIX (DARUNAVIR AND COBICISTAT) — FDA approvalGILEAD SCIENCES, INC.

Sponsor: JANSSEN PRODS. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →fda approvals ↗

Feb 27, 2026approval183d agoDILTIAZEM HYDROCHLORIDE — FDA approvalDILTIAZEM HYDROCHLORIDE

Sponsor: MACLEODS PHARMS LTD. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →DILTIAZEM HYDROCHLORIDE →fda approvals ↗

Feb 27, 2026approval183d agoSILIQ (BRODALUMAB) — FDA approvalBausch Health US LLC

Sponsor: VALEANT LUXEMBOURG. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 27, 2026approval183d agoZEPZELCA (LURBINECTEDIN) — FDA approvallurbinectedin

Sponsor: JAZZ. Form: POWDER. Route: INTRAVENOUS

full page →lurbinectedin →fda approvals ↗

Feb 27, 2026approval183d agoPALYNZIQ (PEGVALIASE-PQPZ) — FDA approvalBIOMARIN PHARMACEUTICAL INC

Sponsor: BIOMARIN PHARM. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 27, 2026approval183d agoCALCITRIOL — FDA approvalSun Pharmaceutical Industries Ltd

Sponsor: HUMANWELL PURACAP. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 27, 2026approval183d agoPREZCOBIX (COBICISTAT) — FDA approvalGILEAD SCIENCES, INC.

Sponsor: JANSSEN PRODS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 27, 2026approval183d agoDULOXETINE HYDROCHLORIDE — FDA approvalduloxetine hydrochloride DR

Sponsor: ALMATICA. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

full page →duloxetine hydrochloride DR →fda approvals ↗

Feb 27, 2026approval183d agoIZERVAY (AVACINCAPTAD PEGOL SODIUM) — FDA approvalavacincaptad pegol sodium

Sponsor: ASTELLAS. Form: SOLUTION. Route: INTRAVITREAL

full page →avacincaptad pegol sodium →fda approvals ↗

Feb 27, 2026approval183d agoREBLOZYL (LUSPATERCEPT-AAMT) — FDA approvalluspatercept

Sponsor: CELGENE CORP. Form: POWDER. Route: SUBCUTANEOUS

full page →luspatercept →fda approvals ↗

Feb 27, 2026approval183d agoYUVIWEL (NAVEPEGRITIDE) — FDA approvalnavepegritide

Sponsor: ASCENDIS. Form: POWDER. Route: SUBCUTANEOUS

full page →navepegritide →fda approvals ↗

Feb 27, 2026approval183d agoSIVEXTRO (TEDIZOLID PHOSPHATE) — FDA approvaltedizolid phosphate

Sponsor: CUBIST PHARMS LLC. Form: TABLET. Route: ORAL

full page →tedizolid phosphate →fda approvals ↗

Feb 27, 2026approval183d agoSOGROYA (SOMAPACITAN-BECO) — FDA approvalsomatriptan albumin bound LA

Sponsor: NOVO NORDISK INC. Form: SOLUTION. Route: SUBCUTANEOUS

full page →somatriptan albumin bound LA →fda approvals ↗

Feb 27, 2026approval183d agoSOGROYA (SOMAPACITAN-BECO) — FDA approvalsomatriptan albumin bound LA

Sponsor: NOVO NORDISK INC. Form: SOLUTION. Route: SUBCUTANEOUS

full page →somatriptan albumin bound LA →fda approvals ↗

Feb 27, 2026approval183d agoSOGROYA (SOMAPACITAN-BECO) — FDA approvalsomatriptan albumin bound LA

Sponsor: NOVO NORDISK INC. Form: SOLUTION. Route: SUBCUTANEOUS

full page →somatriptan albumin bound LA →fda approvals ↗

Feb 27, 2026approval183d agoSIVEXTRO (TEDIZOLID PHOSPHATE) — FDA approvaltedizolid phosphate

Sponsor: CUBIST PHARMS LLC. Form: POWDER. Route: INTRAVENOUS

full page →tedizolid phosphate →fda approvals ↗

Feb 27, 2026approval183d agoDESMOPRESSIN ACETATE — FDA approvalFerring Pharmaceuticals Inc

Sponsor: CAPLIN. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Week of Mar 2, 2026

Mar 2, 2026approval180d agoMETRONIDAZOLE — FDA approvalMETRONIDAZOLE

Sponsor: INNOGENIX. Form: TABLET. Route: ORAL

full page →METRONIDAZOLE →fda approvals ↗

Mar 2, 2026approval

← prev

page 1 of 12

Week of Feb 23, 2026

Week of Mar 2, 2026